Home › Calculator › BBOT Dividend Calculator 2026
BBOT Dividend Calculator 2026
No dividendHealthcareBridgeBio Oncology Therapeutics Inc. · NASDAQ
Price: $2.66 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
BBOT is not a dividend-focused stock
BBOT pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
BBOT Dividend Yield
BridgeBio Oncology Therapeutics Inc. (BBOT) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BBOT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About BridgeBio Oncology Therapeutics Inc. (BBOT) — Dividend Analysis 2026
BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and phosphoinositide 3-kinase malignancies in the United States. The company develops BBO-8520, an orally bioavailable small molecule direct inhibitor, which is in Phase I clinical trial for the treatment of patients with KRASG12C mutant non-small cell lung cancer; and BBO-11818, an orally bioavailable small molecule pan-KRAS inhibitor, which is in Phase I clinical trial for the treatment of patients with KRAS G12D and KRAS G12V cell-derived xenograft models. It is also involved in the development of BBO-10203, an orally bioavailable small molecule, which is in Phase I clinical trial for the treatment of patients with HER2+ breast cancer, HR+/HER2- breast cancer, KRAS mutant colorectal cancer, and KRAS mutant non-small cell lung cancer; and precision oncology assets for patients with tumors. The company was incorporated in 2016 is headquartered in South San Francisco, California.
BBOT Dividend & DRIP — Frequently Asked Questions
Does BBOT pay a dividend?
No. BridgeBio Oncology Therapeutics Inc. (BBOT) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of BBOT?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does BBOT have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. BBOT has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to BBOT
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BBOT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BBOT position with:
🌍 BBOT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BBOT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BBOT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BBOT Dividend Payment Schedule
BBOT pays quarterly — 4 times per year. Ex-div: —.
📊 BBOT vs Healthcare Benchmarks
How BBOT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BBOT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BBOT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-10-01 | 126 | $3.94 | $496.00 | ||
| F-InKind | 2026-10-01 | 343 | $3.94 | $1.4K | ||
| F-InKind | 2026-10-01 | 1,047 | $3.94 | $4.1K | ||
| F-InKind | 2026-10-01 | 1,047 | $3.94 | $4.1K | ||
| A-Award | 2026-09-10 | 43,700 | $5.52 | $241.2K | ||
| A-Award | 2026-09-10 | 9,038 | — | — | ||
| F-InKind | 2026-09-10 | 203 | $5.52 | $1.1K | ||
| F-InKind | 2026-07-01 | 125 | $7.80 | $975.00 | ||
| F-InKind | 2026-07-01 | 343 | $7.80 | $2.7K | ||
| F-InKind | 2026-07-01 | 1,047 | $7.80 | $8.2K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare BBOT with peers: BBOT vs ANAB · BBOT vs KOD · BBOT vs MNMD
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BBOT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
BridgeBio Oncology Therapeutics Inc. (BBOT) is currently trading at $2.66, trading near its 52-week low. It does not currently pay a regular dividend.
Does BBOT Pay a Dividend? BridgeBio Oncology Therapeutics Inc. Dividend Status
BridgeBio Oncology Therapeutics Inc. (BBOT) is a healthcare stock trading at $2.66. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest BBOT News
LiveProjected your BBOT DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.